Correction: LabTech launches MicroStreak in US
Friday, 13 June, 2008
In our online story LabTech launches MicroStreak in the US on June 11, we incorrectly stated that LabTech Systems had received royalties from sales.
The company is anticipating royalties but they have not been received yet. LabTech Systems has instead received licence payments of $4.9 million to date from licencee bioMerieux, and is entitled to receive up to a total of $11.2 million.
The original story has been corrected. We apologise for the error.
Liquid fat treatment provides hope for rare childhood disease
A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in...
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
